Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report

Allergic DiseasesImmunotherapy

Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma

J Allergy Clin Immunol.

Pfaar O, Bachert C, Kuna P, Panzner P, Džupinová M, Klimek L, van Nimwegen MJ, Boot JD, Yu D, Opstelten DJE, de Kam PJ

doi: 10.1016/j.jaci.2018.11.018.

Immunotherapy

Health Economic Analysis of Allergen Immunotherapy (AIT) for the Management of Allergic Rhinitis, Asthma, Food Allergy and Venom Allergy: A Systematic Overview

Allergy.

Asaria M, Dhami S, van Ree R, Gerth van Wijk R, Muraro A, Roberts G, Sheikh A

doi: 10.1111/all.13254.

Immunotherapy

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

Clin Transl Allergy.

Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A, Ansotegui IJ, Calderon M, Cingi C, Durham S, van Wijk RG, Halken S, Hamelmann E, Hellings P, Jacobsen L, Knol E, Larenas-Linnemann D, Lin SY, Maggina V, Oude-Elberink H, Pajno G, Panwankar R, Pastorello E, Pitsios C, Rotiroti G, Timmermans F, Tsilochristou O, Varga EM, Wilkinson J, Williams A, Worm M, Zhang L, Sheikh A

doi: 10.1186/s13601-017-0159-6.

Allergic DiseasesImmunotherapy

Allergen immunotherapy and asthma

Pediatr Allergy Immunol.

Tosca MA, Olcese R, Licari A, Ciprandi G

doi: 10.1111/pai.13161.

Allergic DiseasesImmunotherapy

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Allergy.

Schmid JM, Würtzen PA, Siddhuraj P, Jogdand P, Petersen CG, Dahl R, Erjefält JS, Hoffmann HJ

doi: 10.1111/all.14264.

Allergic DiseasesImmunotherapy

Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1

J Allergy Clin Immunol.

Tabar AI, Prieto L, Alba P, Nieto A, Rodríguez M, Torrecillas M, Huertas B, Gómez E, Fernández FJ, Blanca M, Rodríguez D, Palacios R

doi: 10.1016/j.jaci.2019.02.029.

Immunotherapy

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

JAMA.

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR

doi: 10.1001/jama.2016.21040.

Immunotherapy

Nasal Allergen Neutralising IgG₄ Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

J Allergy Clin Immunol.

Shamji MH, Kappen J, Abubakar-Waziri H, Zhang J, Steveling E, Watchman S, Kouser L, Eifan A, Switzer A, Varrichi G, Marone G, Couto-Francisco NC, Calderon M, Durham SR

doi: 10.1016/j.jaci.2018.09.039.

T Cells

The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy

J Allergy Clin Immunol.

Bacher P, Scheffold A

doi: 10.1016/j.jaci.2018.10.016.

Related content

Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma

Health Economic Analysis of Allergen Immunotherapy (AIT) for the Management of Allergic Rhinitis, Asthma, Food Allergy and Venom Allergy: A Systematic Overview

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

Allergen immunotherapy and asthma

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

Nasal Allergen Neutralising IgG4 Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy

Nasal Allergen Neutralising IgG₄ Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy